-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Ono Pharmaceutical Co., Ltd.- Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean

Reuters·10/08/2026 08:02:48

Please log in to view news